Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 38,869 | 31,960 | 27,976 | 30,728 | 24,126 |
| Operating Income | -38,869 | -31,960 | -27,976 | -30,728 | -24,126 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | 3,065 | 2,242 | 4,467 | 3,462 | -59 |
| Pre-tax Income | -35,804 | -29,718 | -23,509 | -27,266 | -24,186 |
| Net Income Continuous | -35,804 | -29,718 | -23,509 | -27,266 | -24,186 |
| Net Income | $-35,804 | $-29,718 | $-23,509 | $-27,266 | $-24,186 |
| EPS Basic Total Ops | -1.26 | -1.09 | -0.92 | -1.13 | -1.01 |
| EPS Basic Continuous Ops | -1.26 | -1.09 | -0.92 | -1.13 | -1.01 |
| EPS Diluted Total Ops | -1.26 | -1.09 | -0.92 | -1.13 | -1.01 |
| EPS Diluted Continuous Ops | -1.26 | -1.09 | -0.92 | -1.13 | -1.01 |
| EBITDA(a) | $-38,702 | $-31,833 | $-27,850 | $-30,420 | $-24,013 |